References

• 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
• 2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
• 2003Current and Emerging Infectious Risks of Blood Transfusions333 cited
• 2003The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations264 cited
• 2005Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT)96 cited
• 2005Residual risk of transfusion-transmitted viral infections in Spain, 1997-2002, and impact of nucleic acid testing51 cited
• 1995Infectious disease markers in blood donors in northern Thailand41 cited
• 2005Impact of nucleic acid amplification technology (NAT) in Italy in the three years following implementation (2001-2003)37 cited
• 2002A statistical method for the estimation of window-period risk of transfusion-transmitted HIV in donor screening under non-steady state10 cited
• 1997Whose Blood Is Safer?10 cited
• 2007Routine HIV screening among blood donors in Buenos Aires (Argentina): Results from six years’ experience and report of a single window-period donation9 cited

Cited by

No citing works inside the corpus for this window.